AG
DVAX

Aperio Group’s Dynavax Technologies DVAX Stock Holding History

Aperio Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$156K Buy
34,971
+15,868
+83% +$71.8K ﹤0.01% 2345
2020
Q3 		$83K Sell
19,103
-5,477
-22% -$39.1K ﹤0.01% 2330
2020
Q2 		$218K Buy
+24,580
New +$124K ﹤0.01% 2152
2019
Q3 		– Sell
-919
Closed -$4K – 2437
2019
Q2 		$4K Buy
+919
New +$5.33K ﹤0.01% 2869
2014
Q4 		– Sell
-2,630
Closed -$38K – 1885
2014
Q3 		$38K Sell
2,630
-219
-8% -$3.16K ﹤0.01% 1724
2014
Q2 		$46K Buy
+2,849
New +$43K ﹤0.01% 1713

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aperio Group's DVAX Position: Q4 2020 in Review

Aperio Group increased its Dynavax Technologies (DVAX) stake by 83% in Q4 2020, buying an estimated $71.8K and bringing the position to 34,971 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

Aperio Group first reported a position in DVAX in Q2 2014 and has held it in 6 quarters since. The position peaked at $218K in Q2 2020. 144 funds tracked by Wall St. Rank hold DVAX as of Q4 2020.

  • Aperio Group held 34,971 shares of Dynavax Technologies worth $156K as of Q4 2020.
  • Aperio Group bought 15,868 Dynavax Technologies shares in Q4 2020, an estimated $71.8K.
  • Dynavax Technologies made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2345 holding.
  • Aperio Group first reported a position in Dynavax Technologies in Q2 2014 and has held it in 6 quarters since.
  • Aperio Group's Dynavax Technologies position peaked at $218K in Q2 2020.
  • 144 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.